Optiscan Imaging (OIL.AX) Akcija Kursas
Optiscan Imaging Kursas
Optiscan Imaging pajamos traukėsi 12,5 % per metus per pastaruosius 19 metus iki 448 769,00 AUD. Optiscan Imaging grynoji marža dabar yra −1 556,7 %, sumažėjo nuo −417,9 % prieš kelerius metus.
Optiscan Imaging akcijos kaina
Gaukite šiuos duomenis per Eulerpool API
100 000 užklausų/mėn. nemokamai · be kortelės
Optiscan Imaging akcija ir akcijų analizė
Dažnai užduodami klausimai apie Optiscan Imaging akciją
The business model of Optiscan Imaging Ltd focuses on developing and commercializing advanced medical imaging technologies. The company specializes in the design and manufacture of confocal laser endomicroscopes, which are used in various medical applications. Optiscan Imaging aims to improve the diagnosis and treatment of diseases through their innovative imaging solutions. By leveraging their expertise in advanced imaging technologies, the company aims to provide healthcare professionals with high-quality and real-time cellular imaging during medical procedures. Optiscan Imaging Ltd's business model is centered around offering cutting-edge medical imaging technologies that deliver precise and detailed cellular imaging for improved patient outcomes.
Optiscan Imaging Ltd is primarily active in the medical technology and healthcare industries.
The main competitors of Optiscan Imaging Ltd in the market include companies such as Carl Zeiss Meditec AG, NIDEK CO., LTD., and Topcon Corporation.
Optiscan Imaging Ltd is a renowned company specializing in medical imaging technologies. Established in [year], Optiscan has achieved significant milestones in the field of diagnostic imaging. The company is known for its innovative optical imaging systems, such as confocal microscopy, which provide high-resolution cellular images for diagnostic purposes. Optiscan Imaging Ltd has a rich history of research and development, consistently striving to push the boundaries of medical imaging. With its advanced imaging solutions, Optiscan continues to contribute to the progression of healthcare.
Optiscan Imaging Ltd has achieved several significant milestones. The company successfully developed and patented a revolutionary confocal endomicroscopy technology, which enables real-time, high-resolution imaging of living tissue. Optiscan Imaging Ltd also received clearance from the U.S. Food and Drug Administration (FDA) for its confocal endomicroscopy system, facilitating its entry into the American market. Furthermore, the company collaborated with renowned medical institutions and researchers worldwide to conduct clinical studies and validate the efficacy of its imaging technology. Optiscan Imaging Ltd's relentless dedication to innovation and research has positioned it as a leader in the field of real-time tissue imaging.
Optiscan Imaging Ltd is primarily present in Australia.
Optiscan Imaging Ltd is a company known for its strong commitment to innovation and excellence in medical imaging. With a vision to improve patient outcomes, Optiscan prides itself on providing cutting-edge solutions for real-time cellular imaging. The company's corporate philosophy revolves around leveraging advanced technology to enhance diagnostic accuracy and enhance the effectiveness of medical procedures. Optiscan Imaging Ltd values integrity, collaboration, and a customer-centric approach, ensuring that their products and services meet the evolving needs of the medical community. By prioritizing research and development, Optiscan aims to revolutionize the field of medical imaging, while maintaining a steadfast dedication to quality and patient care.
Pagal dabartinį kursą Optiscan Imaging akcija kainuoja 0,07 EUR (0,12 AUD).
Optiscan Imaging akcija (OIL.AX) kotiruojama 1 biržose, įskaitant: ASX (OIL.AX).
Optiscan Imaging Ltd is a leading provider of high-quality microscope systems and components for scientific research, medical diagnostics, and industrial testing and quality assurance. The company was founded in Melbourne, Australia in 1994 and has since expanded its operations worldwide. Today, Optiscan Imaging is a global company that delivers innovative technologies and products to meet the needs of its customers in various industries.
pelnas Optiscan Imaging yra 448 769,00 AUD. Šis skaičius grindžiamas dabartiniais finansiniais duomenimis ir atspindi įmonės verslo rezultatus.
grynasis pelnas Optiscan Imaging yra −6,99 mln. AUD. Grynasis pelnas atspindi įmonės pelningumą po visų išlaidų atimties.
Kainų ir nuomos santykis (KGV) Optiscan Imaging šiuo metu yra −17,94. KGV lygina dabartinę akcijos kainą su pelnu už akciją ir padeda investuotojams įvertinti Optiscan Imaging akcijos vertę.
Kainų ir pardavimų santykis (KUV) Optiscan Imaging šiuo metu yra 279,21. KUV lygina rinkos kapitalizaciją su metinėmis pajamomis ir yra Optiscan Imaging akcijos įvertinimo metrika.
Eulerpool kokybės balas Optiscan Imaging yra 4/10.
Optiscan Imaging ISIN yra AU000000OIL4. ISIN (International Securities Identification Number) yra pasaulinė unikali vertybinių popierių identifikacijos sistema.
Optiscan Imaging WKN yra 932111. WKN (Wertpapierkennnummer) yra šešiaženklė vokiška vertybinių popierių identifikacijos sistema.
Optiscan Imaging prekybos žymė yra OIL.AX. Ši biržos žymė naudojama Optiscan Imaging akcijoms prekiauti biržoje.
Optiscan Imaging akcija
Optiscan Imaging Pagrindiniai konkurentai
Optiscan Imaging Biržos simbolis
Optiscan Imaging FIGI
Visos Optiscan Imaging pagrindinės charakteristikos ir giluminė analizė
Mūsų akcijų analizė Optiscan Imaging akcijai apima svarbius finansinius rodiklius, tokius kaip apyvarta, pelnas, P/E santykis, P/S santykis, EBIT, taip pat informaciją apie dividendes. Be to, mes nagrinėjame aspektus, tokius kaip akcijos, rinkos kapitalizacija, skolos, nuosavas kapitalas ir įsipareigojimai Optiscan Imaging. Jei ieškote išsamesnės informacijos šiais klausimais, mūsų poskyriuose galite rasti išsamias analizes: